Market Closed -
Nyse
04:00:01 2024-04-26 pm EDT
|
5-day change
|
1st Jan Change
|
495.4
USD
|
+0.30%
|
|
-1.15%
|
-5.91%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
278,521
|
332,732
|
472,941
|
495,373
|
486,945
|
455,762
|
-
|
-
|
Enterprise Value (EV)
1 |
308,214
|
359,278
|
495,037
|
514,300
|
519,854
|
479,771
|
470,236
|
452,758
|
P/E ratio
|
20.5
x
|
21.9
x
|
27.8
x
|
25
x
|
22.1
x
|
24.8
x
|
16.7
x
|
14.8
x
|
Yield
|
1.41%
|
1.38%
|
1.12%
|
1.21%
|
1.38%
|
1.59%
|
1.76%
|
1.94%
|
Capitalization / Revenue
|
1.15
x
|
1.29
x
|
1.64
x
|
1.53
x
|
1.31
x
|
1.14
x
|
1.06
x
|
0.99
x
|
EV / Revenue
|
1.27
x
|
1.4
x
|
1.72
x
|
1.59
x
|
1.4
x
|
1.2
x
|
1.1
x
|
0.98
x
|
EV / EBITDA
|
13.8
x
|
14.2
x
|
18.3
x
|
16.2
x
|
14.3
x
|
12.4
x
|
10.8
x
|
9.53
x
|
EV / FCF
|
18.8
x
|
17.9
x
|
24.9
x
|
22
x
|
20.2
x
|
20.8
x
|
15
x
|
13.2
x
|
FCF Yield
|
5.32%
|
5.6%
|
4.02%
|
4.55%
|
4.94%
|
4.81%
|
6.65%
|
7.59%
|
Price to Book
|
4.84
x
|
5.1
x
|
6.28
x
|
6.18
x
|
5.48
x
|
4.54
x
|
3.95
x
|
3.45
x
|
Nbr of stocks (in thousands)
|
947,415
|
948,821
|
941,851
|
934,349
|
924,925
|
920,080
|
-
|
-
|
Reference price
2 |
294.0
|
350.7
|
502.1
|
530.2
|
526.5
|
495.4
|
495.4
|
495.4
|
Announcement Date
|
1/15/20
|
1/20/21
|
1/19/22
|
1/13/23
|
1/12/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
242,155
|
257,141
|
287,597
|
324,162
|
371,622
|
398,824
|
429,399
|
461,290
|
EBITDA
1 |
22,405
|
25,296
|
27,073
|
31,835
|
36,330
|
38,803
|
43,486
|
47,508
|
EBIT
1 |
19,685
|
22,405
|
23,970
|
28,435
|
32,358
|
35,232
|
39,394
|
43,295
|
Operating Margin
|
8.13%
|
8.71%
|
8.33%
|
8.77%
|
8.71%
|
8.83%
|
9.17%
|
9.39%
|
Earnings before Tax (EBT)
1 |
17,981
|
20,742
|
22,310
|
26,343
|
29,112
|
26,491
|
35,651
|
39,611
|
Net income
1 |
13,839
|
15,403
|
17,285
|
20,120
|
22,381
|
18,082
|
27,014
|
30,008
|
Net margin
|
5.71%
|
5.99%
|
6.01%
|
6.21%
|
6.02%
|
4.53%
|
6.29%
|
6.51%
|
EPS
2 |
14.33
|
16.03
|
18.08
|
21.18
|
23.86
|
19.94
|
29.61
|
33.42
|
Free Cash Flow
1 |
16,392
|
20,123
|
19,889
|
23,404
|
25,682
|
23,075
|
31,259
|
34,360
|
FCF margin
|
6.77%
|
7.83%
|
6.92%
|
7.22%
|
6.91%
|
5.79%
|
7.28%
|
7.45%
|
FCF Conversion (EBITDA)
|
73.16%
|
79.55%
|
73.46%
|
73.52%
|
70.69%
|
59.47%
|
71.88%
|
72.32%
|
FCF Conversion (Net income)
|
118.45%
|
130.64%
|
115.07%
|
116.32%
|
114.75%
|
127.62%
|
115.71%
|
114.5%
|
Dividend per Share
2 |
4.140
|
4.830
|
5.600
|
6.400
|
7.290
|
7.865
|
8.734
|
9.607
|
Announcement Date
|
1/15/20
|
1/20/21
|
1/19/22
|
1/13/23
|
1/12/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
72,337
|
73,743
|
80,149
|
80,332
|
80,894
|
82,787
|
91,931
|
92,903
|
92,361
|
94,427
|
99,796
|
98,735
|
98,916
|
100,687
|
106,037
|
EBITDA
1 |
6,508
|
6,312
|
7,738
|
7,934
|
8,290
|
7,873
|
9,056
|
9,078
|
9,533
|
8,663
|
8,928
|
9,682
|
10,312
|
9,654
|
10,375
|
EBIT
1 |
5,712
|
5,541
|
6,950
|
7,132
|
7,462
|
6,891
|
8,086
|
8,057
|
8,526
|
7,689
|
7,931
|
8,706
|
9,309
|
8,782
|
9,794
|
Operating Margin
|
7.9%
|
7.51%
|
8.67%
|
8.88%
|
9.22%
|
8.32%
|
8.8%
|
8.67%
|
9.23%
|
8.14%
|
7.95%
|
8.82%
|
9.41%
|
8.72%
|
9.24%
|
Earnings before Tax (EBT)
1 |
5,290
|
5,110
|
6,517
|
6,665
|
6,946
|
6,215
|
7,332
|
7,229
|
7,692
|
6,859
|
1
|
7,787
|
8,367
|
7,766
|
8,419
|
Net income
1 |
4,086
|
4,071
|
5,027
|
5,070
|
5,262
|
4,761
|
5,611
|
5,474
|
5,841
|
5,455
|
-1,409
|
5,841
|
6,326
|
5,845
|
6,447
|
Net margin
|
5.65%
|
5.52%
|
6.27%
|
6.31%
|
6.5%
|
5.75%
|
6.1%
|
5.89%
|
6.32%
|
5.78%
|
-1.41%
|
5.92%
|
6.4%
|
5.81%
|
6.08%
|
EPS
2 |
4.280
|
4.260
|
5.270
|
5.340
|
5.550
|
5.030
|
5.950
|
5.820
|
6.240
|
5.830
|
-1.530
|
6.309
|
6.858
|
6.355
|
7.014
|
Dividend per Share
2 |
1.450
|
1.450
|
1.450
|
1.650
|
1.650
|
1.650
|
1.650
|
1.880
|
-
|
1.880
|
1.882
|
1.971
|
1.971
|
1.971
|
2.009
|
Announcement Date
|
10/14/21
|
1/19/22
|
4/14/22
|
7/15/22
|
10/14/22
|
1/13/23
|
4/14/23
|
7/14/23
|
10/13/23
|
1/12/24
|
4/16/24
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
29,693
|
26,546
|
22,096
|
18,927
|
32,909
|
24,010
|
14,475
|
-
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
3,003
|
Leverage (Debt/EBITDA)
|
1.325
x
|
1.049
x
|
0.8162
x
|
0.5945
x
|
0.9058
x
|
0.6188
x
|
0.3329
x
|
-
|
Free Cash Flow
1 |
16,392
|
20,123
|
19,889
|
23,404
|
25,682
|
23,075
|
31,259
|
34,360
|
ROE (net income / shareholders' equity)
|
25.7%
|
24.9%
|
24.1%
|
25.7%
|
26.8%
|
25%
|
25.8%
|
25.6%
|
ROA (Net income/ Total Assets)
|
8.48%
|
8.3%
|
8.44%
|
8.79%
|
8.62%
|
7.1%
|
8.72%
|
9.13%
|
Assets
1 |
163,196
|
185,589
|
204,748
|
228,956
|
259,713
|
254,608
|
309,869
|
328,699
|
Book Value Per Share
2 |
60.80
|
68.80
|
80.00
|
85.70
|
96.10
|
109.0
|
125.0
|
143.0
|
Cash Flow per Share
2 |
19.10
|
23.10
|
23.40
|
27.60
|
31.00
|
34.40
|
37.10
|
42.00
|
Capex
1 |
2,071
|
2,051
|
2,454
|
2,802
|
3,386
|
3,470
|
3,857
|
4,035
|
Capex / Sales
|
0.86%
|
0.8%
|
0.85%
|
0.86%
|
0.91%
|
0.87%
|
0.9%
|
0.87%
|
Announcement Date
|
1/15/20
|
1/20/21
|
1/19/22
|
1/13/23
|
1/12/24
|
-
|
-
|
-
|
Last Close Price
495.4
USD Average target price
567.4
USD Spread / Average Target +14.54% Consensus |
1st Jan change
|
Capi.
|
---|
| -5.91% | 456B | | +13.93% | 125B | | +18.37% | 101B | | -0.28% | 39.69B | | -33.18% | 36.86B | | -5.28% | 20.05B | | -13.82% | 3.08B | | -28.58% | 337M |
Other Managed Healthcare
|